American Society of Clinical Oncology

SHERPA: White

People

  1. Iasonos
    Iasonos
  2. Aghajanian
    Aghajanian
  3. Zhou
    Zhou
  4. O'Cearbhaill
    O'Cearbhaill
  5. Grisham
    Grisham
  6. Hensley
    Hensley
  7. Tew
    Tew
  8. Konner
    Konner
  9. Makker
    Makker
  10. Sabbatini
    Sabbatini

Groups

  1. Biostatistics Service (50)
  2. Epidemiology and Biostatistics (50)
  3. Department of Medicine (47)
  4. Solid Tumor Oncology Division (45)
  5. Gynecology Disease Management Team (33)
  6. GDMT, Medicine (32)
  7. Gynecologic Medicine Service (32)
  8. Hematologic Malignancies, Division of (18)
  9. Surgery (18)
  10. Nursing (13)
Search Within
  1. "Meeting abstract"
  2. "Alexia Iasonos"
Formats
  1. Meeting Abstract (50)
Groups
  1. Biostatistics Service (50)
  2. Epidemiology and Biostatistics (50)
  3. Department of Medicine (47)
  4. Solid Tumor Oncology Division (45)
  5. Gynecology Disease Management Team (33)
  6. GDMT, Medicine (32)

More Groups

People
  1. Alexia Iasonos (50)
  2. Carol Aghajanian (24)
  3. Qin Zhou (24)
  4. Roisin O'Cearbhaill (16)
  5. Martee Hensley (14)
  6. Rachel Grisham (14)

More People

Years
  1. 2023 (2)
  2. 2022 (6)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (3)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (50)

Results (50)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenic germline variants in patients with endometrial cancer across diverse ancestries
    Meeting Abstract

    Liu, Y. L.; Gordhandas, S.; Arora, K.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E. E.; Zhou, Q.; Iasonos, A.; Selenica, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Germline variants in non- BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival
    Meeting Abstract

    Kahn, R. M.; Selenica, P.; Boerner, T.; Xiao, Y.; Sia, T.; Sheehan, M.; Zhou, Q.; Iasonos, A.; Grisham, R. N.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer
    Meeting Abstract

    Shen, S.; Ma, W.; Zhou, Q.; Iasonos, A.; Zhang, Y.; Ross, D. S.; Makker, V.; Chui, M. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Central nervous system (CNS) outcomes and progression patterns in patients with RET fusion-positive lung cancers treated with selpercatinib
    Meeting Abstract

    Murciano-Goroff, Y. R.; Falcon, C. J.; Lin, S. T.; Dhawan, A.; Grimaldi, G.; Liu, D.; Wilhelm, C.; Thomas, R.; Iasonos, A.; Drilon, A. E.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II trial of IDO-inhibitor, BMS-986205 (IDO), and PD-1 inhibitor, nivolumab (NIVO), in recurrent or persistent endometrial cancer (EC; CA017-056)
    Meeting Abstract

    Kyi, C.; Rubinstein, M. M.; Shah, P.; Zhou, Q.; Iasonos, A.; Liu, Y.; Ramirez, L.; Paroder, V.; Green, A.; Friedman, C. F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Basket study of oral progesterone antagonist onapristone extended release (ONA-XR) in progesterone receptor positive (PR+) recurrent granulosa cell (GCT), low-grade serous ovarian (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Zhou, Q.; Iasonos, A.; Girshman, J.; Shah, P.; Jang, D.; Kyi, C.; Cohen, S. M.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dysfunctional CD8+T cells in the tumor microenvironment are associated with response to nivolumab in mismatch repair deficient (dMMR) or hypermutated ovarian (OVCA) or endometrial cancer (EC)
    Meeting Abstract

    Friedman, C. F.; Zhou, Q.; Iasonos, A.; Holland, A.; Ramirez, L.; Grisham, R. N.; Guo, R.; Lichtman, S. M.; Kyi, C.; Makker, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
    Meeting Abstract

    DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers
    Meeting Abstract

    Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Basket study of the oral progesterone antagonist onapristone ER in women with progesterone receptor positive (PR plus ) recurrent granulosa cell tumor (GCT), low-grade serous ovarian cancer (LGSOC), or endometrioid endometrial cancer (EEC)
    Meeting Abstract

    Grisham, R. N.; Li, K.; Iasonos, A.; Girshman, J.; Cadoo, K. A.; Kyi, C.; Makker, V.; Cohen, S. M.; O'Cearbhaill, R. E.; Sabbatini, P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save